Draft Guidance for Industry on Self-Identification of Generic Drug Facilities, Sites, and Organizations; Availability; Correction

---
identifier: "/us/fr/2012-22784"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Draft Guidance for Industry on Self-Identification of Generic Drug Facilities, Sites, and Organizations; Availability; Correction"
title_number: 0
title_name: "Federal Register"
section_number: "2012-22784"
section_name: "Draft Guidance for Industry on Self-Identification of Generic Drug Facilities, Sites, and Organizations; Availability; Correction"
positive_law: false
currency: "2012-09-17"
last_updated: "2012-09-17"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2012-22784"
document_type: "notice"
publication_date: "2012-09-17"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
fr_citation: "77 FR 57094"
fr_volume: 77
docket_ids:
  - "Docket No. FDA-2012-D-0881"
fr_action: "Notice; correction."
---


#  Draft Guidance for Industry on Self-Identification of Generic Drug Facilities, Sites, and Organizations; Availability; Correction

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Notice; correction.

**SUMMARY:**

The Food and Drug Administration (FDA) is correcting a notice that appeared in the *Federal Register* of Monday, August 27, 2012 (77 FR 51811). The document announced a draft guidance for industry entitled “Self-Identification of Generic Drug Facilities, Sites, and Organizations.” The document was published with an incorrect docket  number. This document corrects that error.

**FOR FURTHER INFORMATION CONTACT:**

Joyce Strong, Office of Policy, Food and Drug Administration, 10903 New Hampshire Ave. Bldg. 32, Rm. 3208, Silver Spring, MD 20993-0002, 301-796-9148.

**SUPPLEMENTARY INFORMATION:**

In FR Doc. 2012-20946, appearing on page 51811 in the *Federal Register* of Monday, August 27, 2012, the following correction is made:

1. On page 51811, in the third column, the docket number is corrected to read “FDA-2012-D-0881”.

Dated: August 30, 2012.

Leslie Kux,

Assistant Commissioner for Policy.